Beyond Meat (BYND) Q4 Earnings on Deck: Options Market Prices in a Massive 32% Earnings Explosion

Beyond Meat (BYND), the plant-based nutrient maker, volition study its Q4 2025 results connected March 25. The options marketplace is pricing successful a monolithic 32% determination successful either direction in BYND stock after the study — acold supra its accustomed 7%–10% post-earnings swings. For a banal trading successful penny territory, this volatility signals that traders are bracing for a full “re-valuation” of the company.

• Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions

• Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Investors volition beryllium watching whether request stabilizes and whether the institution tin dilatory its income declines. Wall Street expects income to driblet astir 18% twelvemonth implicit year to astir $63 million. Analysts besides spot a nonaccomplishment of astir $0.10 per share, narrower than the $0.65 nonaccomplishment a twelvemonth ago.

Earlier this week, Beyond Meat shared aboriginal numbers for the 4th quarter. The institution expects Q4 gross of astir $61 million, beneath the astir $63 cardinal analysts were looking for. Full-year gross is expected to autumn astir 10% to $275 million.

Demand remains weak. U.S. retail income are down, and the institution is inactive relying connected discounts to thrust volumes.

There are caller issues going into this report.

On March 16, Beyond Meat announced that it has delayed its yearly filing owed to a reappraisal of inventory levels. It besides said it expects a worldly weakness successful interior controls. That raises questions astir however good the concern is being managed.

At the aforesaid time, the institution received a Nasdaq (NDAQ) informing aft the banal stayed beneath $1 for 30 days. It present has until August 31, 2026, to hole this. If not, a reverse banal divided is likely.

Ahead of the print, Mizuho expert John Baumgartner maintained a Sell standing connected BYND with a $1 terms target, highlighting respective concerns. He noted that the company’s aboriginal Q4 gross of astir $61 cardinal missed Wall Street estimates and points to ongoing request weakness.

He besides flagged the delayed 10-K filing, tied to inventory accounting issues and anemic interior controls, arsenic a antagonistic signal. Beyond that, helium warned that income trends stay nether unit crossed cardinal markets and expressed uncertainty astir the company’s determination into macromolecule drinks, fixed beardown competition. Overall, helium sees constricted upside and continued downside hazard for the stock.

Turning to TipRanks, Wall Street has a Moderate Sell statement standing connected Beyond Meat banal based connected 2 Sell recommendations. The average 12-month BYND banal terms target of $0.75 indicates 5.50% upside potential.